Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3715547

View statistics

In Collections

This item can be found in the following collections:

Scholarly Publications

Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma (vol 126, pg 93, 2020)

Decaudin, D.; Leitz, E.F.D.; Nemati, F.; Tarin, M.; Naguez, A.; Zerara, M.; ... ; Alsafadi, S. (2023)

Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma (vol 126, pg 93, 2020)

Article / Letter to editor

All authors: Decaudin, D.; Leitz, E.F.D.; Nemati, F.; Tarin, M.; Naguez, A.; Zerara, M.; Marande, B.; Vivet-Noguer, R.; Halilovic, E.; Fabre, C.; Jochemsen, A.; -Roman, S.R.; Alsafadi, S.

Date: 2023-04-11

Journal: European Journal of Cancer

Volume: 184

Pages: 199 - 199

DOI: doi:10.1016/j.ejca.2023.02.004

Link: https://www.ejcancer.com/article/S0959-8049(23)00077-1/fulltext